Загрузка...
Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2
Metastatic pancreatic cancer (PC) has been associated with a considerably poor prognosis. Due to its toxicity, first-line combination chemotherapy is limited to patients with a good performance status (PS). Previously nab-paclitaxel plus gemcitabine has been demonstrated to improve the overall survi...
Сохранить в:
| Опубликовано в: : | Oncol Lett |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907314/ https://ncbi.nlm.nih.gov/pubmed/27347207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4667 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|